Dec 29, 2020 | News, Regulatory
The U.S. Food and Drug Administration (FDA) has made their REMS requirements for transmucosal immediate-release fentanyl (TIRF) products more rigorous to minimize inappropriate prescriptions for the strong and highly addictive opioid. The REMS guidelines serve as a...
Apr 17, 2020 | News, Regulatory
The FDA announced on Thursday (4/16) it was temporarily allowing compounding for necessary hospital drugs due to the mass shortage from Covid. The majority of the 13 commonly used drugs listed in the policy are anesthetic or analgesic drugs, which helps support...
